To determine whether there is an unconfounded association between neonatal intraventricular hemorrhage (IVH) and lenticulostriate vasculopathy (LSV (also known as thalamostriate or mineralizing vasculopathy)).
INTRODUCTION
Lenticulostriate vasculopathy (LSV (also known as thalamostriate or mineralizing vasculopathy)) was first reported in the 1960s after a congenital rubella epidemic in Philadelphia. 1 Postmortem histology of the brains from affected babies demonstrated a highly regionalized vasculitis. For unknown reasons, the pathologic lesion was limited exclusively to the blood vessel walls of the thalami and basal ganglia. In 1985, Grant et al. 2 provided the first cranial imaging description of the lesion. Later in the same decade, Teele et al. 3 studied this question exhaustively during their review of nearly 4500 head ultrasounds (HUS) at Children's Hospital, Boston. In their work, Teele et al. 3 found 12 previously unreported cases of LSV. Eight of these babies had congenital infections (cytomegalovirus, n ¼ 5; rubella, n ¼ 2; and syphilis, n ¼ 1), but three had trisomy 13 in the absence of apparent infection. One infant had no pathologic diagnosis. Four of the babies had undergone autopsies, including histologic sections of the brain. All of these children had vascular pathology remarkable for basophilic deposits consistent with mineralization and hypercellularity. The deposits stained positively with Schiff reagent and Prussian blue (indicator for iron), but not with von Kóssa (indicator for calcium) or phosphotungstic acid hematoxylin (indicator for fibrin). Teele et al. 3 were the first to conclude that the focal vasculopathy observed in autopsy specimens accounted for the echogenicity that was seen on the cranial ultrasounds.
Since then, more than 25 separate reports describing the occurrence of LSV have been published. 4 With the exception of small prospective studies by Kriss and Kriss, 5 as well as Makhoul et al., 4 the publications have only detailed the findings of retrospective studies or case reports, including one such report by two members (D.Y. and T.B.-A.) of our research team. 6 In these many instances, along with the congenital infections and the chromosomal abnormalities previously mentioned, a wide variety of perinatal conditions, including maternal-fetal alcohol exposure, 7 perinatal asphyxia, 8 twin-to-twin transfusion syndrome, 9 as well as other possible etiologies were thought to be related to the neurovasculopathy found in LSV. However, none of the previous studies, whether old or new, used regression modeling to control for possible confounding. As mentioned above, until recently, LSV was thought to be uncommon. However, it may be that the growing awareness of its presence and the advent of more sophisticated cranial imaging devices with improved resolution may account for some, if not all, of the reported increase in LSV prevalence. For example, in 2000, Coley et al. 10 reported that more than 4.2% of neonates in their study were found to have the lesion. More recently, Hemachandra et al., 11 in a retrospective study published in this Journal, also found that LSV was not uncommon (prevalence of 4.6% (21 of 453 reviewed cranial images)). Furthermore, they were the first to report an association between LSV and insufficient exposure to antenatal antibiotics and corticosteroids, a relationship germane to the contemporary management of preterm premature rupture of the membranes in pregnant women.
The purpose of our current work is to share a finding from the data set collected during the conduct of the Magnesium and Neurologic Endpoints Trial (MagNET). Extending the recent observation of El Ayoubi et al. 12 (28 of 70 neonates with LSV had either intraventricular hemorrhage (IVH) or periventricular leucomalacia (PVL), in this study, through the use of multivariate logistic regression, the reader will find we have confirmed that a statistically significant and unconfounded relationship exists between neonatal IVH and LSV, the latter being a lesion that we, as did Hemachandra et al. 11 and Coley et al., 10 have found to be more common than reported in the older medical literature.
METHODS
MagNET was a randomized clinical trial designed to assess whether or not magnesium sulfate infusion administered under the clinical circumstance of preterm labor could decrease neonatal IVH, infant death, and, in survivors, cerebral palsy. The original report of the unexpected total pediatric mortality associated with tocolytic doses of magnesium sulfate, appeared as a cautionary Research Letter in The Lancet. 13 It was accompanied by a Commentary solicited by the editors from two prominent London physicians.
14 A detailed methodology and the official report of the adverse outcomes that occurred in MagNET can be found in the American Journal of Obstetrics and Gynecology, 15 thus, they will appear here only in abbreviated form.
In brief, during the course of the study, in addition to randomizing mothers in preterm labor to magnesium sulfate, other tocolytic, or saline control, we collected information on epidemiologic variables, and we obtained numerous biological specimens at delivery. Among the latter were samples of maternal (antecubital vein) and umbilical cord venous blood drawn, at the time of obstetric delivery, for the determination of serum ionized magnesium (iMg) levels. Immediately after their collection, blood samples were centrifuged for 10 minutes at 1000 g. Aliquots of pipetted sera were frozen, and then later sent for blinded evaluation of iMg content by the National Institutes of Health, Bethesda, MD, using the AVL 988-4 analyzer (Graz, Austria). Most of the results for this portion of MagNET were reported in the Journal of Pediatrics 16 and Obstetrics and Gynecology.
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To help determine whether or not congenital infection (as expressed by the fetal inflammatory response syndrome (FIRS) might be present), we evaluated the umbilical cord at delivery for a specific inflammatory cytokine, namely, interleukin-6 (IL-6), as well as histologic funisitis (transmural migration of neutrophils from the vascular lumen through the muscularis of one or more umbilical cord blood vessel walls). Umbilical cord venous blood was collected aseptically in endotoxin-free glass collection tubes containing liquid ethylene-diaminetetraacetic acid (EDTA) ((Becton-Dickinson, Franklin Lakes, NJ) and aprotinin (Sigma A6279, Sigma Chemical Company, St. Louis, MO). It was then centrifuged at 1000 g for 10 minutes. The supernatant plasma was pipetted off the red cell mass, aliquoted into 1.25 ml Eppendorf storage tubes, and frozen at À701C until assayed. Concentrations of plasma IL-6 were measured by the standard commercial enzyme-linked immunoassay ((ELISA), Endogen, Cambridge, MA).
We also collected placental membrane cultures using a method described by Hillier et al. 18 To avoid bacterial contamination from the vagina, we aseptically separated the amnion from the chorion, and then swabbed between their interior surfaces distant from the site of membrane rupture. Using microbiologic selective media, we obtained cultures for aerobes, anaerobes, ureaplasma, mycoplasma, and chlamydia. The bacteriology findings from this study were previously reported as a Research Letter in The Lancet 19 and here, in the pages of the Journal of Perinatology; 20 the inflammatory cytokine and the umbilical cord and placental histology were reported elsewhere. 21, 22 Screening histopathologic examinations of the umbilical cords and placentas were done by a staff pathologist. The placentas were examined after fixation in 10% buffered formalin. Following gross examination, the trimmed placental discs were weighed and sectioned. Standard cuts included a cross-section of the umbilical cord. All relevant findings, including funisitis, were confirmed at secondary review by an especially trained perinatal pathologist. The umbilical cord venous blood plasma IL-6 concentrations from the placentas being evaluated were unknown to all of the pathologists participating in the study.
In regard to neonatal follow-up, in the first month after delivery, surviving infants underwent a minimum of three comprehensive HUS examinations (done in the first, second, and fourth week of life), in addition to their routine medical examination. Cranial ultrasonography was performed with 128XP or Sequoia ultrasound machines (Acuson, Mountain View, CA) and 7.5 or 8.5-MHz transducers through the anterior fontanel. The final cranial-imaging diagnoses, including grading of IVH and determination of LSV (predicated on the search for IVH), were made by two experienced pediatric radiologists (DY, TB-A) who, as mentioned above, were well versed in identifying LSV because of their previous work. 6 A final diagnosis and grading of intracranial hemorrhage, 23 when present, was made by consensus. Both pediatric radiologists were masked to information contained among the biological variables.
In order to determine the occurrence of cerebral palsy among surviving children, follow-up neuromotor examinations were conducted for members of the cohort in especially designated clinics held at 4, 8, 12, and 18 corrected months of age. Diagnoses of cerebral palsy and Bayley Psychomotor Development Index Scores 24 were determined and assigned by a developmental pediatrician at the 18-month visit. As had been the standard in the earlier conduct of the study, in order to maintain an unbiased evaluation, the developmentalist was masked to the information contained in the biological variables datafile.
Statistical Analysis
We used Student's t-test, the Fisher exact test (Stata statistical software (5.0), 1997. College Station, TX: Stata Corporation), and multivariate logistic regression (LogXact (4), 1999; Cambridge, MA: CYTEL Software Corporation), where appropriate. All tests of statistical significance were two-sided, with significance being defined as a<0.05. The sample size determinations for the trial were based on anticipated, but now shown to be erroneous, reductions in the occurrence of neonatal IVH following the use of antenatal intravenous magnesium sulfate. For a ¼ 0.05, 1Àb (power) ¼ 80%, two-tailed, the total number of babies needed was calculated to be n ¼ 140. As it turned out, although enrollment in the MagNET was suspended by the Institutional Review Board of the University of Chicago because of excess pediatric mortality among babies randomized to tocolytic magnesium, the size of the entire study population, although insufficient for determining any putative neuroprotective effect for magnesium sulfate, did, in fact, meet the necessary power requirements in regard to questions involving the outcome of neonatal intraventicular hemorrhage.
RESULTS
Of 157 eligible gravidas who were in preterm labor, 149 consented to participate in the trial. These women gave birth to 165 babies (133 singletons, and 16 pairs of twins). Mothers in each treatment arm were found to be similar in age, race, parity, gestational length, fetal plurality, and absence or presence of preterm premature rupture of the membranes. Thus, the maternal randomization was balanced. Among demographic maternal variables (age, race, parity, marital status, insurance payor status, history of cigarette smoking or cocaine usage), there were no differences between the mothers of infants who had or did not have IVH. Among 140 babies on whom we have both neonatal IVH and LSV data, IVH was diagnosed in 17.1% (24 of 140) of them (Grade I, n ¼ 19; Grade II, n ¼ 0; Grade III, n ¼ 5; and, Grade IV, n ¼ 0 (Papile criteria) 23 ), and LSV (see image of brain in Figure 1 ) was found in 10.0% (14 of 140). Among the 14 babies who had LSV, 50.0% (7 of 14) also had IVH (Grade I, n ¼ 5; Grade III, n ¼ 2). This is compared with 126 babies who did not have LSV, among which only 5.6% (7 of 126) had IVH (two-sided Fisher's exact test, p ¼ 0.003).
Among numerous maternal and obstetric variables that were evaluated, only vaginal bleeding within 1 week of parturition (p ¼ 0.02) and maternal serum iMg level at delivery (p ¼ 0.01) were found to be significantly associated with IVH in the neonate by univariate analysis (Table 1) . Among numerous neonatal variables, only glucocorticoid usage in the Neonatal Intensive Care Unit (NICU) ((p ¼ 0.03) and the occurrence of LSV (p ¼ 0.003) were significantly associated with neonatal IVH. None of the babies had evidence for a congenital infection or trisomy (previously reported by some (see above) to occur in babies having LSV).
Using multivariate logistic regression analysis, we controlled for the possible confounding of the association between LSV and neonatal IVH by the other significant univariates, as well as verylow-birth-weight (VLBW, <1500 g), a well-documented predictor of IVH. Regressing the antenatal variables in the same model, the association between IVH and LSV remained significant (adjusted (adj) odds ratio (OR), 9.8; 95% confidence interval (CI) 1.3 to 73.1; p ¼ 0.03) ( Table 2) . We have previously reported the significant, unconfounded association between higher levels of maternal serum ionized magnesium circulating at the time of delivery and the subsequent outcome of IVH in babies. 25 Also, when regressing a multivariate model with the postnatal glucocorticoid variable, the association between LSV and IVH remained statistically significant.
Of some further interest, when evaluating the acuity of IVH, we found that 14.3% (2 of 14) babies with LSV had Grade III lesions, whereas 1.6% (2 of 126) of babies without LSV had disease this advanced (p ¼ 0.08 (when controlled for VLBW, p ¼ 0.13)). Thus, there may be a trend in the data to suggest that F when LSV is present F the associated grade of neonatal IVH may be greater.
DISCUSSION
In previous data analyses from the MagNET, we found, and reported as a published scientific abstract, a relationship between LSV and funisitis, 26 as well as neonatal IVH. Although funisitis may be an independent predictor of LSV, we do not find any evidence in these data to suggest that funisitis is a predictor of IVH in the newborn (see line entry for ''Funisitis'' in Table 1 ). There is, however, a significant, unconfounded association between LSV and IVH, and one that may prove to be of some clinical value, especially given the various morbid and mortal sequelae of the latter. We are hoping that the statistical relationship of which our research group, and the descriptive data that others, have now reported may help to elevate the clinical finding of LSV to one of enhanced concern among those in our academic community. Is it possible, for example, that some yet to be understood relationship between LSV and IVH, and the consequences of the latter, will ultimately provide an explanation for some of the unexpected mortalities in MagNET? 13 The question is asked in view of our previous report of an association between serious neurologic injury (Grade III IVH) and pediatric deaths observed in our study 27 as well as our previous report of a significant association between levels of maternal serum ionized magnesium circulating at the time of delivery and the subsequent outcome of neonatal intraventicular hemorrhage. 16 The anticoagulant properties of magnesium have now been reported by several investigators. [28] [29] [30] In regard to the evolving question of whether neonates who have LSV will become children with neurodevelopmental disabilities (a natural concern given the location (thalamus and basal ganglia) of the LSV lesion), Chamnanvanakij et al. 31 have already suggested that such a relationship exists. Further, Hemachandra et al., 11 in the pages of this Journal, reported muscle tone abnormalities in some children who had neonatal LSV. In our own work, as previously reported here, 32 we were able to follow 13 of 14 children who had LSV, and 103 children without the lesion, up to age 18 months, at which time Bayley psychomotor development index (PDI) scores were determined. Of interest, 31% (four of 13) of children with precedent LSV had PDI scores more than one standard deviation (SD) below the population mean (<85, (mean 100, SD 15)), whereas only 14% (14 of 103) of those without it had scores that low. The difference showed a trend, but not statistically significant, when controlled for VLBW.
With all things considered, we remain optimistic that our ongoing research, and the important contributions of other investigators in this field, will ultimately clarify these intriguing questions in regard to the essential significance of LSV and its influence on the health outcomes of babies who have it. At the very least, it would appear that the dismissal of any possible clinical relevance for LSV may be premature.
